GABRIELA VILLAFUERTE: Open Payments
NPI 1659020550 · TRABUCO CANYON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 36 payments from 12 companies in 2025. Trend: 2023 $713 · 2024 $2,119 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $295 |
| Teva Pharmaceuticals USA, Inc. | 4 | $105 |
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| E.R. Squibb & Sons, L.L.C. | 2 | $66 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| Noven Therapeutics, LLC | 2 | $47 |
| Lilly USA, LLC | 1 | $35 |
| Alkermes, Inc. | 1 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Bausch Health US, LLC | 1 | $19 |
Products named: VRAYLAR, COBENFY, AUSTEDO XR, Sunosi, ABILIFY ASIMTUFII, Xelstrym, REXULTI, UZEDY.
Industry payments across CA — which companies pay providers there.
